HER2-low Breast Cancer Clinical Trials in Guangzhou, Guangdong
4 recruitingGuangzhou, Guangdong, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer
HER2-low Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.566 enrolled2 locationsNCT06957886
Recruiting
Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
HER2-low Breast CancerHER2-positive Breast CancerTrastuzumab-rezetecan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University300 enrolled1 locationNCT07358182
Recruiting
Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
Breast CancerHER2-low Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University255 enrolled1 locationNCT05466786
Recruiting
Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
Breast NeoplasmsHER2-low Breast CancerAntibody-drug Conjugates
Sun Yat-sen University700 enrolled1 locationNCT06877416